Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-25 @ 3:12 AM
Ignite Modification Date: 2025-12-26 @ 1:51 AM
NCT ID: NCT00408005
Term: White blood cell decreased
Organ System: Investigations
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCv4
Notes: None
Study: NCT00408005
Study Brief: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG008 61 38 143 View
EG009 18 11 62 View
EG000 54 54 1563 View
EG001 0 0 368 View
EG002 253 110 372 View
EG003 62 35 147 View
EG004 353 125 451 View
EG005 70 40 219 View
EG006 2 2 285 View
EG007 0 0 80 View